Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind infant trial of Sabin inactivated poliovirus vaccine cross-neutralization, immunogenicity, and safety
CTR20211257Phase 3Active
- Sponsor
- Wuhan Institute of Biological Products
- Start
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Wuhan Institute of Biological Products. Started Jun 2021; status: active.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on CTR20211257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211257.